Skip to main content
. 2018 Apr 26;23(9):1008–1015. doi: 10.1634/theoncologist.2017-0629

Figure 3.

image

The distribution of representative targeted genetic alterations between the younger and older patients with lung adenocarcinoma. The comparative analysis of KRAS mutations (A), ALK arrangements (B), EGFR mutations (C), EGFR mutation subtypes (D), HER2‐targeted genetic alterations (E), and STK11 mutations (F) between the younger and the older groups. Statistical significance was defined as p < .05.

Abbreviation: WT, wild type.